Novel use of water soluble glucan oligomer isolated from saccharomyces cerevisiae IS2 for prevention and treatment of avian flu

The present invention relates to novel use of water soluble glucan oligomer having a M.W. ranging from 1.000 to 10.000 prepared by treating insoluble beta-glucan isolated the cell wall of yeast variant IS2 with commercially available beta-glucan hydrolyzing enzymes for the preparation of pharmaceuti...

Full description

Saved in:
Bibliographic Details
Main Author MOON WON KOOK,KIM DONG WOO,CHUNG BONG HYUN,PARK JEONG HOON
Format Patent
LanguageEnglish
Published 07.02.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel use of water soluble glucan oligomer having a M.W. ranging from 1.000 to 10.000 prepared by treating insoluble beta-glucan isolated the cell wall of yeast variant IS2 with commercially available beta-glucan hydrolyzing enzymes for the preparation of pharmaceutical composition to treat and prevent avian flu, in a mammal including human in need thereof, therefore, it can be used as the therapeutic or health care food for treating and preventing avian flu.
Bibliography:Application Number: CN200580002741